Chengdu Zeling Biomedical Technology Co. Ltd.
PrivateLast Round
Series C
Jan 12, 2026
Total Funding Raised
$185.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Chengdu Zeling Biomedical Technology Co. Ltd. operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series C round in January 2026.
Chengdu Zeling Biomedical Technology Co. Ltd. is a biotechnology company that focuses on the research and development of innovative drug candidates, particularly small molecule inhibitors for the treatment of cancer and inflammatory, autoimmune, and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chengdu Zeling Biomedical Technology Co. Ltd. Comparables
Compare Chengdu Zeling Biomedical Technology Co. Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accro Bioscience Inc. | 81% | |
| Sironax | 81% | |
| Ventus Therapeutics | 77% |
For institutional investors. Book with your work email.
Chengdu Zeling Biomedical Technology Co. Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 12, 2026 | ||||
| Series B Extension | Aug 5, 2025 | ||||
| Series B | Nov 24, 2023 | ||||
| Series A | Dec 8, 2021 |
For institutional investors. Book with your work email.
Chengdu Zeling Biomedical Technology Co. Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanchi Ventures | Series C |
| Tencent Exploration | Series C |
| True Light Capital | Series C |
| Sichuan Innovation Development Investment Management Co., Ltd. | Series B |
| Huajin Capital | Series C, Series B |
| 5Y Capital | Series C, Series B Extension |
| Shenzhen New Henglida Capital Management | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
$86M round led by True Light Capital and Qiming Venture Partners.
- Dec 8, 2021
Raised $17M with participation from Shenzhen New Henglida Capital Management.
For institutional investors. Book with your work email.
Chengdu Zeling Biomedical Technology Co. Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chengdu Zeling Biomedical Technology Co. Ltd.'s valuation, stock price, and market status.
Is Chengdu Zeling Biomedical Technology Co. Ltd. a public or private company?
Chengdu Zeling Biomedical Technology Co. Ltd. is a private company.
What is the current stock price of Chengdu Zeling Biomedical Technology Co. Ltd.?
Chengdu Zeling Biomedical Technology Co. Ltd. is a private company, so its shares have no public market price. Caplight tracks Chengdu Zeling Biomedical Technology Co. Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chengdu Zeling Biomedical Technology Co. Ltd. worth (valuation)?
Valuation information for Chengdu Zeling Biomedical Technology Co. Ltd. is not publicly available.
Can I buy Chengdu Zeling Biomedical Technology Co. Ltd. stock?
Chengdu Zeling Biomedical Technology Co. Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chengdu Zeling Biomedical Technology Co. Ltd.'s last funding round?
Chengdu Zeling Biomedical Technology Co. Ltd.'s most recent funding round was Series C on January 12, 2026.
Who are the main investors in Chengdu Zeling Biomedical Technology Co. Ltd.?
Key investors in Chengdu Zeling Biomedical Technology Co. Ltd. include True Light Capital, Qiming Venture Partners.
Will Chengdu Zeling Biomedical Technology Co. Ltd. IPO soon?
No public IPO plans have been announced for Chengdu Zeling Biomedical Technology Co. Ltd..
How can I track Chengdu Zeling Biomedical Technology Co. Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Chengdu Zeling Biomedical Technology Co. Ltd.'s shares on secondary markets.